Want to see KCDMY full AI Analyst Report?
Top Page
Kimberly-Clark de Mexico SAB de CV
(OTC:KCDMY)
Select Model
Select Model
Rating:60Neutral
Price Target:
$10.50
â–¼(-10.94% Downside)
Action:Reiterated
Date:10/27/26
The score is primarily held back by balance-sheet risk (high leverage) and weak technical momentum (below key moving averages with negative MACD). These are partially offset by strong underlying profitability and cash flow, a supportive valuation (moderate P/E and high dividend yield), and an earnings call that was constructive on margins and cost savings but cautious on near-term demand and costs.
Positive Factors
Consumer Products Growth
Repeated Consumer Products growth and healthy market shares indicate durable brand relevance in essential hygiene categories. Continued volume and price/mix contributions support revenue resilience, while strong category positions can help preserve customer retention and competitive standing.
Negative Factors
High Leverage
The sharp increase in leverage makes the company more sensitive to earnings fluctuations and financing conditions. Higher debt can constrain capital allocation flexibility and increase the importance of sustained cash generation, particularly if demand or margins weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Consumer Products Growth
Repeated Consumer Products growth and healthy market shares indicate durable brand relevance in essential hygiene categories. Continued volume and price/mix contributions support revenue resilience, while strong category positions can help preserve customer retention and competitive standing.
Read all positive factors
Kimberly-Clark de Mexico SAB de CV (KCDMY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.86B
Dividend Yield6.07%
Average Volume (3M)20.79K
Price to Earnings (P/E)13.9
Beta (1Y)0.16
Revenue Growth13.74%
EPS Growth24.96%
CountryUS
Employees9,400
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)13.30
Shares Outstanding309,794,800
10 Day Avg. Volume0
30 Day Avg. Volume20,791
Financial Highlights & Ratios
PEG Ratio-2.43
Price to Book (P/B)15.97
Price to Sales (P/S)2.23
P/FCF Ratio19.02
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue0.12
Enterprise Value/Gross Profit0.30
Enterprise Value/Ebitda0.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.72
Revenue Forecast (FY)$3.19B
Kimberly-Clark de Mexico SAB de CV Business Overview & Revenue Model
Company Description
Kimberly-Clark de México, S. A. B. de C. V., through its subsidiaries, manufactures and distributes a wide array of disposable consumer goods for everyday use across Mexico. The company's diverse product offering spans several categories: infant c...
How the Company Makes Money
Kimberly-Clark de México makes money primarily by manufacturing and selling branded hygiene and tissue products in Mexico. Revenue is generated through (1) consumer retail sales, where products such as diapers, feminine care, adult care, and tissu...
Kimberly-Clark de Mexico SAB de CV Earnings Call Summary
Earnings Call Date:Oct 20, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Jan 19, 2027
Earnings Call Sentiment Positive
The call was broadly positive, supported by higher year-to-date EBITDA and EPS, margin expansion, substantial cost savings, a strong balance sheet, continued Consumer Products growth, and encouraging private label, pet food, and innovation initiatives. However, the quarter also reflected flat total sales, weak consumer demand, declines in Away from Home and exports, higher SG&A and financing costs, and persistent cost pressures. Management remained confident in execution and potential 2027 improvement, but acknowledged that the near-term environment remains challenging.Positive Updates
Consumer Products Delivered a Fifth Consecutive Quarter of Growth
Consumer Products sales increased 1.8%, with balanced contributions from 0.9% volume growth and 0.9% price and mix growth. The business grew for the fifth consecutive quarter, and management said market shares remained very healthy.
Negative Updates
Quarterly Sales Were Flat Year-Over-Year
Total sales were MXN 13.4 billion, in line with last year, with volume and price mix both flat.
Read all updates
Q3-2026 Updates
Positive
Negative
Consumer Products Delivered a Fifth Consecutive Quarter of Growth
Consumer Products sales increased 1.8%, with balanced contributions from 0.9% volume growth and 0.9% price and mix growth. The business grew for the fifth consecutive quarter, and management said market shares remained very healthy.
Read all positive updates
Company Guidance
Management expects weak consumer demand to stretch through the end of the year, with cost pressures continuing through the fourth quarter, maybe at slightly lower levels, and expects a slightly better fourth quarter for Away from Home and a much better 2027. Going into 2027, it expects steady improvements in demand, improving growth rates and increased, although still moderate, domestic spending; Consumer Products could get back to growing at the rate seen in the first half of the year, or mid-single digit, if domestic consumption picks up. Private label will likely a little bit more than double in size this year, with the same thing expected to happen next year, while CapEx is expected to remain around between MXN 100 million and MXN 120 million for the year in 2027 and following years. The company remains comfortable staying within its 25% to 27% margin long-term range, expects its KCM plus initiatives and cost reduction program to accelerate, and expects a resolution on Kenvue Mexico by the fourth quarter.Kimberly-Clark de Mexico SAB de CV Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
42
Neutral
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.30B | 51.94B | 54.78B | 53.31B | 51.06B | 46.89B |
| Gross Profit | 23.00B | 20.19B | 22.38B | 20.70B | 16.77B | 15.79B |
| EBITDA | 15.36B | 13.97B | 16.09B | 15.23B | 11.58B | 10.79B |
| Net Income | 7.94B | 7.11B | 7.83B | 7.01B | 4.94B | 4.49B |
Balance Sheet | ||||||
| Total Assets | 56.45B | 45.71B | 52.11B | 53.92B | 53.54B | 48.78B |
| Cash, Cash Equivalents and Short-Term Investments | 20.23B | 9.68B | 15.58B | 16.86B | 16.92B | 12.27B |
| Total Debt | 30.03B | 21.36B | 28.10B | 29.72B | 34.15B | 29.83B |
| Total Liabilities | 51.01B | 38.46B | 44.70B | 47.00B | 48.51B | 43.06B |
| Stockholders Equity | 5.37B | 7.25B | 7.41B | 6.92B | 5.03B | 5.72B |
Cash Flow | ||||||
| Free Cash Flow | 9.83B | 6.09B | 8.10B | 11.08B | 6.18B | 4.65B |
| Operating Cash Flow | 11.35B | 7.80B | 10.60B | 12.76B | 8.32B | 6.80B |
| Investing Cash Flow | -1.28B | -1.72B | -1.30B | -311.39M | -2.15B | -2.14B |
| Financing Cash Flow | -287.88M | -11.02B | -13.50B | -9.83B | -1.32B | -11.07B |
Kimberly-Clark de Mexico SAB de CV Technical Analysis
Negative
11.79
Price Trends
10.86
Negative
10.92
Negative
11.08
Negative
Market Momentum
-0.24
Positive
30.36
Neutral
8.61
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KCDMY, the sentiment is Negative. The current price of 11.79 is above the 20-day moving average (MA) of 10.38, above the 50-day MA of 10.86, and above the 200-day MA of 11.08, indicating a bearish trend. The MACD of -0.24 indicates Positive momentum. The RSI at 30.36 is Neutral, neither overbought nor oversold. The STOCH value of 8.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KCDMY.
Kimberly-Clark de Mexico SAB de CV Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $374.48B | 23.94 | 29.55% | 2.68% | 3.52% | -3.74% | |
74 Outperform | $25.44B | 32.89 | 18.21% | 1.14% | 2.69% | 46.04% | |
70 Outperform | $140.57B | 13.75 | 58.26% | 3.41% | -17.45% | 8.84% | |
70 Outperform | $37.09B | 21.94 | 16.06% | 5.40% | 1.75% | 16.81% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | $5.86B | 13.95 | 165.92% | 6.07% | 13.74% | 24.96% | |
56 Neutral | $10.64B | 18.26 | -1893.55% | 5.66% | -5.41% | -26.46% |
* Consumer Defensive Sector Average
KCDMY
Kimberly-Clark de Mexico SAB de CV
9.81
0.58
6.31%
CHD
Church & Dwight
107.23
20.66
23.87%
CLX
Clorox
88.00
-19.02
-17.77%
PG
Procter & Gamble
161.57
15.44
10.57%
UL
Unilever
65.26
2.93
4.70%
KVUE
Kenvue, Inc.
19.31
5.76
42.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.